Current treatments, which range from steroids to immunosuppressants and targeted biologics, often fail to control the disease. Some 10% to 15% of people with lupus die prematurely. Lupus patients pursue CAR-T trials despite trial deaths, amid hopeful remission stories and ongoing safety investigations. Please provide your email address to receive an email when new articles are posted on .